GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Blau Farmaceutica SA (BSP:BLAU3) » Definitions » 5-Year Yield-on-Cost %

Blau Farmaceutica (BSP:BLAU3) 5-Year Yield-on-Cost % : 3.06 (As of Apr. 28, 2024)


View and export this data going back to 2021. Start your Free Trial

What is Blau Farmaceutica 5-Year Yield-on-Cost %?

Blau Farmaceutica's yield on cost for the quarter that ended in Dec. 2023 was 3.06.


The historical rank and industry rank for Blau Farmaceutica's 5-Year Yield-on-Cost % or its related term are showing as below:

BSP:BLAU3' s 5-Year Yield-on-Cost % Range Over the Past 10 Years
Min: 0.04   Med: 2.69   Max: 5.5
Current: 3.06


During the past 8 years, Blau Farmaceutica's highest Yield on Cost was 5.50. The lowest was 0.04. And the median was 2.69.


BSP:BLAU3's 5-Year Yield-on-Cost % is ranked better than
61.52% of 499 companies
in the Drug Manufacturers industry
Industry Median: 2.22 vs BSP:BLAU3: 3.06

Competitive Comparison of Blau Farmaceutica's 5-Year Yield-on-Cost %

For the Drug Manufacturers - Specialty & Generic subindustry, Blau Farmaceutica's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Blau Farmaceutica's 5-Year Yield-on-Cost % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Blau Farmaceutica's 5-Year Yield-on-Cost % distribution charts can be found below:

* The bar in red indicates where Blau Farmaceutica's 5-Year Yield-on-Cost % falls into.



Blau Farmaceutica 5-Year Yield-on-Cost % Calculation

Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.

Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.

Therefore, Yield-on-Cost of Blau Farmaceutica is calculated as

Yield-on-Cost=Dividend Yield %*(1+Dividend Growth Rate)^5

Blau Farmaceutica  (BSP:BLAU3) 5-Year Yield-on-Cost % Explanation

Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.


Blau Farmaceutica 5-Year Yield-on-Cost % Related Terms

Thank you for viewing the detailed overview of Blau Farmaceutica's 5-Year Yield-on-Cost % provided by GuruFocus.com. Please click on the following links to see related term pages.


Blau Farmaceutica (BSP:BLAU3) Business Description

Traded in Other Exchanges
N/A
Address
Rodovia Raposo Tavares, No. 2833, Km 30.5, Barro Branco, Cotia, SP, BRA, 06705-030
Blau Farmaceutica SA is engaged in the manufacturing, development and commercialization of complex private-label drugs for the institutional segment. The Company's business activities cover institutional and retail segments, and are divided into four units: 1) Biologicals are a heterogeneous class of products that can be produced using raw materials from biological materials and biotechnological procedures. 2) Oncology line is made up of oral and injectable drugs intended for treating cancer, which encompasses a number of therapeutic classes. 3) Specialties line is made up of products that are used in the hospital's daily routine, in the specialized treatments for infectious diseases and special treatments. 4) Others consist of prescription and non-prescription over-the-counter drugs.

Blau Farmaceutica (BSP:BLAU3) Headlines

No Headlines